ArticleFrontiers in bioengineering and biotechnology2022

Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy.

Agnes Bonifacius et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.